These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33667264)

  • 1. Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence.
    Giovenco D; Gill K; Fynn L; Duyver M; O'Rourke S; van der Straten A; Morton JF; Celum CL; Bekker LG
    PLoS One; 2021; 16(3):e0248307. PubMed ID: 33667264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
    Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
    J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Disclosure of PrEP Use on Adherence Among African Young Women in an Open-Label PrEP Study: Findings from HPTN 082.
    Beauchamp G; Hosek S; Donnell D; Chan KCG; Anderson PL; Dye BJ; Mgodi N; Bekker LG; Delany-Moretlwe S; Celum C;
    AIDS Behav; 2024 May; 28(5):1512-1521. PubMed ID: 37768427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
    Tapsoba JD; Cover J; Obong'o C; Brady M; Cressey TR; Mori K; Okomo G; Kariithi E; Obanda R; Oluoch-Madiang D; Chen YQ; Drain P; Duerr A
    PLoS Med; 2022 Sep; 19(9):e1004097. PubMed ID: 36095005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
    Celum C; Hosek S; Tsholwana M; Kassim S; Mukaka S; Dye BJ; Pathak S; Mgodi N; Bekker LG; Donnell DJ; Wilson E; Yuha K; Anderson PL; Agyei Y; Noble H; Rose SM; Baeten JM; Fogel JM; Adeyeye A; Wiesner L; Rooney J; Delany-Moretlwe S
    PLoS Med; 2021 Jun; 18(6):e1003670. PubMed ID: 34143779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial.
    Celum CL; Gill K; Morton JF; Stein G; Myers L; Thomas KK; McConnell M; van der Straten A; Baeten JM; Duyver M; Mendel E; Naidoo K; Dallimore J; Wiesner L; Bekker LG
    J Int AIDS Soc; 2020 Nov; 23(11):e25636. PubMed ID: 33247553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
    Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High study participation but diverging adherence levels: qualitatively unpacking PrEP use among adolescent girls and young women over two years in Eastern Cape, South Africa.
    Krogstad Mudzingwa E; de Vos L; Atujuna M; Fynn L; Mugore M; Mabandla S; Hosek S; Celum C; Bekker LG; Daniels J; Medina-Marino A
    J Behav Med; 2024 Apr; 47(2):320-333. PubMed ID: 38081955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
    BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of PrEP Use Disclosure on Adherence in a Cohort of Adolescent Girls and Young Women in South Africa.
    Giovenco D; Pettifor A; Powers KA; Hightow-Weidman L; Pence BW; Edwards JK; Gill K; Morton JF; van der Straten A; Celum C; Bekker LG
    AIDS Behav; 2022 Apr; 26(4):1007-1016. PubMed ID: 34478015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent Girls and Young Women's Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis.
    Young AM; Mancuso N; Atujuna M; Tenza S; Chitukuta M; Kemigisha D; Ngure K; van der Straten A; Garcia M; Szydlo D; Soto-Torres L; Roberts ST
    AIDS Behav; 2023 Dec; 27(12):3941-3951. PubMed ID: 37392268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship dynamics and anticipated stigma: Key considerations for PrEP use among Tanzanian adolescent girls and young women and male partners.
    Jani N; Mathur S; Kahabuka C; Makyao N; Pilgrim N
    PLoS One; 2021; 16(2):e0246717. PubMed ID: 33596216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
    de Vos L; Mudzingwa EK; Fynn L; Atujuna M; Mugore M; Gandhi M; Celum C; Hosek S; Bekker LG; Daniels J; Medina-Marino A
    J Int AIDS Soc; 2023 Sep; 26(9):e26175. PubMed ID: 37758649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa.
    Ndimande-Khoza MN; Katz AWK; Moretlwe-Delany S; Travill D; Rousseau E; Omollo V; Morton J; Johnson R; Bekker LG; Bukusi EA; Baeten J; Celum C; van der Straten A; Roberts ST
    PLoS One; 2023; 18(11):e0292529. PubMed ID: 37963171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial.
    Velloza J; Donnell D; Hosek S; Anderson PL; Chirenje ZM; Mgodi N; Bekker LG; Marzinke MA; Delany-Moretlwe S; Celum C
    Lancet HIV; 2022 Oct; 9(10):e680-e689. PubMed ID: 36087612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre-exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial.
    Velloza J; Hosek S; Donnell D; Anderson PL; Chirenje M; Mgodi N; Bekker LG; Delany-Moretlwe S; Celum C;
    J Int AIDS Soc; 2021 Jun; 24 Suppl 2(Suppl 2):e25731. PubMed ID: 34164929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influences on Early Discontinuation and Persistence of Daily Oral PrEP Use Among Kenyan Adolescent Girls and Young Women: A Qualitative Evaluation From a PrEP Implementation Program.
    Pintye J; O'Malley G; Kinuthia J; Abuna F; Escudero JN; Mugambi M; Awuor M; Dollah A; Dettinger JC; Kohler P; John-Stewart G; Beima-Sofie K
    J Acquir Immune Defic Syndr; 2021 Apr; 86(4):e83-e89. PubMed ID: 33273211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
    Celum CL; Bukusi EA; Bekker LG; Delany-Moretlwe S; Kidoguchi L; Omollo V; Rousseau E; Travill D; Morton JF; Mogaka F; O'Malley G; Barnabee G; van der Straten A; Donnell D; Parikh UM; Kudrick L; Anderson PL; Haberer JE; Wu L; Heffron R; Johnson R; Morrison S; Baeten JM;
    J Int AIDS Soc; 2022 Jul; 25(7):e25962. PubMed ID: 35822945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creating allies: qualitative exploration of young women's preferences for PrEP methods and parents' role in PrEP uptake and user support in urban and rural Zambia.
    Wong CM; Munthali T; Mangunje FG; Katoka ML; Burke HM; Musonda B; Musonda M; Todd CS
    BMC Womens Health; 2024 Jan; 24(1):71. PubMed ID: 38273282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.
    Celum CL; Delany-Moretlwe S; Baeten JM; van der Straten A; Hosek S; Bukusi EA; McConnell M; Barnabas RV; Bekker LG
    J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25298. PubMed ID: 31328444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.